FDA approves updated Moderna, Pfizer COVID vaccines

The Food and Drug Administration said it approved and granted emergency use authorization for updated mRNA COVID-19 vaccines to include a monovalent component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death, the agency said in a statement. Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by Moderna (MRNA) and Pfizer (PFE).